Patent ID: 8461212

Claim:
A method for the treatment of at least one of inflammation, neurodegeneration, carcinogenesis, skin ageing or central nervous system ageing, comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising at least one substituted 1,3-diphenylprop-2-en-1-one derivative represented by formula (I) below: wherein: X1 represents a halogen or a —R1 group or a group corresponding to the following formula: -G1-R1, X2 represents a hydrogen atom or a hydroxy group or an unsubstituted alkyloxy group or a thiol group or an alkylthio group, X3 represents a —R3 group, X4 represents a group corresponding to the following formula: -G4-R4, X5 represents a —R5 group, X6 is an oxygen atom, R3 and R5, which are the same or different, represent an unsubstituted alkyl group, R1 represents a hydrogen atom or an alkyl group substituted or not by a substituent having the formula —COOR6, with R6 representing a hydrogen atom or an alkyl group, R4 represents a hydrogen atom or an alkyl group substituted or not by a substituent having the formula —COOR6, with R6 representing a hydrogen atom or an alkyl group, G1 and G4, which are the same or different, represent an oxygen or sulfur atom, with one of the groups R1 and R4 represents an alkyl group substituted by a substituent having the formula —COOR6, said alkyl group being bound directly to the ring or being associated with a group G according to the formula -GR, the optical and geometrical isomers, racemates, tautomers, salts, and mixtures thereof.